Voloridge Investment Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-13,101
| Closed | -$692K | – | 1222 |
|
|
2024
Q3 | $692K | Sell |
13,101
-542,009
| -98% | -$28.6M | ﹤0.01% | 1059 |
|
|
2024
Q2 | $30.1M | Sell |
555,110
-205,209
| -27% | -$11.1M | 0.11% | 262 |
|
|
2024
Q1 | $53.3M | Buy |
+760,319
| New | +$53.3M | 0.19% | 144 |
|
|
2022
Q1 | – | Sell |
-228,799
| Closed | -$10.4M | – | 1428 |
|
|
2021
Q4 | $10.4M | Sell |
228,799
-8,002
| -3% | -$365K | 0.06% | 449 |
|
|
2021
Q3 | $8.46M | Buy |
+236,801
| New | +$8.46M | 0.05% | 486 |
|
|
2020
Q4 | – | Sell |
-64,475
| Closed | -$1.4M | – | 1367 |
|
|
2020
Q3 | $1.4M | Sell |
64,475
-80,805
| -56% | -$1.75M | 0.01% | 834 |
|
|
2020
Q2 | $3.42M | Buy |
145,280
+113,855
| +362% | +$2.68M | 0.04% | 453 |
|
|
2020
Q1 | $371K | Buy |
+31,425
| New | +$371K | 0.01% | 802 |
|
|
2019
Q4 | – | Sell |
-21,355
| Closed | -$243K | – | 1134 |
|
|
2019
Q3 | $243K | Buy |
+21,355
| New | +$243K | ﹤0.01% | 973 |
|